Campus

Tokyo Tokyo
Osaka Osaka
Nagoya Nagoya

Faculty & Research

Network Activity Report

Healthcare Network

  • Healthcare Network
    32nd meeting

    • Nagoya
    • Number of participants 17

    Subject

    • Why is the “Pharmacy Vision for Patients” not progressing? - What should pharmacists, who are responsible for local medical care, be like?
    • The challenge of starting a business as a pharmacist.

  • Healthcare Network
    36th meeting

    • Tokyo
    • Number of participants 26

    Subject

    • Is living a long life really happiness? ~Healthy life expectancy~
    • The path forward for domestic pharmaceutical companies.

  • Healthcare Network
    34th meeting

    • Osaka
    • Number of participants 17

    Subject

    • Should medical device manufacturers that sell products enter the solution business?
    • What are the success factors when entering the market?
    • Advice on changing jobs.
    • What are the factors behind the stalemate between generic drugs and long-listed drug businesses?

  • Healthcare Network
    35th meeting

    • Tokyo
    • Number of participants 26

    Subject

    • How should laboratories of small and medium-sized domestic pharmaceutical companies compete in the future?
    • Japan's declining birthrate and population strategy.
    • Globalization of major pharmaceutical companies and implications for Japanese companies.

  • Healthcare Network
    31st meeting

    • Nagoya
    • Number of participants 19

    Subject

    • Launching a medical startup ~ Consideration of DX business targeting GPs ~
    • Issues and solutions for the continuing decline in drug prices.

  • Healthcare Network
    33rd meeting

    • Osaka
    • Number of participants 17

    Subject

    • Launching a medical startup ~ Consideration of DX business targeting GPs ~
    • Discuss the declining birthrate.

  • Healthcare Network
    34th meeting

    • Tokyo
    • Number of participants 26

    Subject

    • What should leadership look like? (In particular, what kind of leadership should seniors show?)
    • The role of sales function in an organization - Healthcare industry -

  • Healthcare Network
    32nd meeting

    • Osaka
    • Number of participants 17

    Subject

    • What strategies can companies in the generic drug business take?
    • Addressing the issue of ever-lowering drug prices.

  • Healthcare Network
    30th meeting

    • Nagoya
    • Number of participants 14

    Subject

    • Thinking about pharmaceutical business strategy - Delivering innovative therapeutic drugs to patients -
    • One year after the launch of the high blood pressure treatment aid app, we consider the pros and cons of CureApp's market penetration.

  • Healthcare Network
    29th meeting

    • Nagoya
    • Number of participants 15

    Subject

    • How medical marketing should work in the post-corona era.
    • About the future of pharmaceutical wholesalers.

  • Healthcare Network
    31st meeting

    • Osaka
    • Number of participants 17

    Subject

    • Will Japan need industrial physicians in the future?
    • Thinking about the form of "regional medical cooperation" that has emerged from the experience of the coronavirus pandemic - A case study from the Chubu Medical Area of Okinawa Prefecture -

  • Healthcare Network
    33rd meeting

    • Tokyo
    • Number of participants 51

    Subject

    • The gap between the correctness of corporate reform and the values of employees.
    • Collaboration between venture companies and large companies and employee careers in the healthcare industry.
    • How can pharmaceutical companies balance social contribution with their own profits?

Search by Category